UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A historic music chart moment becomes a practical lesson in money management. This article translates that milestone ...
A simple computer moment can signal bigger trouble. This article explains how a watched mouse move laptop moment can ...
When a beloved soap star hints at a fragile return, it isn’t just headlines that shake. It can ripple into budgets, i...
Celebrity moments on the red carpet can reveal more than fashion. This article uses Kate Upton Justin Verlander to sh...
A $1,000 stake can still grow, even in shaky markets. This guide shows how to identify the smartest stock with $1,000...
A quick daily routine can transform crypto results. This article shows how a focused morning minute: change strategy ...
Gladstone Investment faces a quarterly miss that pressures its 5.7% yield, spotlighting the risks and resilience of a...
A timely analysis of pff’s billion preferred stock exposure reveals how call provisions and a bank-heavy portfolio co...
North Carolina prosecutors seize $61 million in USDT connected to a pig-butchering scam, freezing assets tied to onli...
Andreessen Horowitz is tapping California’s pension funds for the first time, led by CalPERS’ $400 million commitment...
Gold had a remarkable run in 2025, with GLD delivering strong gains. This guide explains what happened, what it means...